http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2275194-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 2004-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2bc1f908485c8680d39cb1fda7265c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e411f438a8adf8ac200c84210708289c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97ecd18cf0790f4022e39b64d2ac4655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17068e232e473b627b51165d966b9679 |
| publicationDate | 2006-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2275194-C1 |
| titleOfInvention | Method and remedy for treating benign hyperplasia processes in endometrium |
| abstract | FIELD: medicine. n SUBSTANCE: method involves administering Indinol as alternative means to hormone medication at a dose of 200 mg per day for 2 months following hysteroscopy operation. Then, the dose is reduced to 10 mg per day during the next 2 months. Kipferon is to be concurrently intravaginally administered at a dose of 1 suppository daily during 10 days. n EFFECT: stimulated estradiol production in liver; enhanced effectiveness of local receptor-correcting and immunomodulating action. n 2 cl, 5 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2787090-C1 |
| priorityDate | 2004-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.